Some characteristics of patients with myelodysplastic syndrome

Abstract

Objective: epidemiological analysis of myelodysplastic syndrome, based on the available retrospective data.Materials and methods: a retrospective analysis of the medical history data of 115 patients (61 men and 54 women) with a diagnosis of myelodysplastic syndrome who received treatment in the hematology department of the «City Hospital № 7 of the city of Rostov-on-Don» in the period from 2010 to 2019.Results: the most likely comorbidities were cardiovascular diseases, which are the main cause of sudden death, and endocrine diseases, which together influence the outcome of myelodysplastic syndrome.Conclusions: there are no individual risk assessment algorithms that could determine the goal setting of therapy in patients with myelodysplastic syndrome, whose life expectancy depends more on the course of concomitant diseases.